Korro Bio (KRRO) Accumulated Expenses (2018 - 2026)

Korro Bio's Accumulated Expenses history runs 9 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• Quarterly Accumulated Expenses fell 63.24% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 63.24% YoY) and the FY2025 annual result came in at $1.8 million, down 50.01% from the prior year.
• Accumulated Expenses was $1.3 million for Q1 2026 at Korro Bio, down from $1.8 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $10.2 million in Q4 2023 and bottomed at $1.3 million in Q1 2026.
• A 5-year average of $4.4 million and a median of $4.9 million in 2023 frame the typical range for Accumulated Expenses.
• Peak annual rise in Accumulated Expenses reached 221.64% in 2023, while the deepest fall reached 65.52% in 2023.
• Korro Bio's Accumulated Expenses stood at $3.2 million in 2022, then soared by 221.64% to $10.2 million in 2023, then tumbled by 63.84% to $3.7 million in 2024, then sank by 50.01% to $1.8 million in 2025, then fell by 27.36% to $1.3 million in 2026.
• Business Quant data shows KRRO's Accumulated Expenses at $1.3 million in Q1 2026, $1.8 million in Q4 2025, and $5.9 million in Q3 2025.